US doctors think an anti-inflammatory drug represents a potential new era of treatment.
It has the potential to reduce the risk of heart attacks by 15 percent and cut deaths caused by cancer by at least half.
During a four-year trial, the drug was administered once every three months to around 10-thousand patients.
But cardiology consultant at Britain’s Cambridge University, Doctor James Rudd, says we shouldn’t get carried away.
Advertisement